Snowflake Equity Securities Without Readily Determinable Fair Value - Cumulative Impairment Loss increased by 0.8% to $61.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 79.9%, from $33.90M to $61.00M.
equity_securities_no_fv_impairment_cumulative| Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $26.60M | $34.00M | $38.00M | $40.10M | $41.10M | $59.90M | $67.00M | $33.90M | $60.50M | $60.50M | $61.00M |
| QoQ Change | — | +27.8% | +11.8% | +5.5% | +2.5% | +45.7% | +11.9% | -49.4% | +78.5% | +0.0% | +0.8% |
| YoY Change | — | — | — | +50.8% | +20.9% | +57.6% | +67.1% | -17.5% | +1.0% | -9.7% | +79.9% |